{
    "clinical_study": {
        "@rank": "132918", 
        "arm_group": [
            {
                "arm_group_label": "Control arm - Standard of Care", 
                "arm_group_type": "No Intervention", 
                "description": "The anastomosis will be created using Standard of Care only"
            }, 
            {
                "arm_group_label": "Device arm - Standard of Care + LifeSeal\u2122 Kit", 
                "arm_group_type": "Experimental", 
                "description": "The anastomosis will be created using Standard of Care + LifeSeal\u2122 Kit"
            }
        ], 
        "brief_summary": {
            "textblock": "A Pilot Study in Subjects Undergoing circular stapled anastomosis created within 10 cm of\n      the anal verge."
        }, 
        "brief_title": "LifeSeal\u2122 Pilot Study in Subjects Undergoing Circular Stapled Anastomosis Created Within 10 cm of the Anal Verge", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Rectal Cancer", 
        "condition_browse": {
            "mesh_term": "Rectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject, or authorized representative, signed a written Informed Consent Form\n\n          2. Subject is 18 years or older\n\n          3. Subject is scheduled for elective open or laparoscopic surgery involving the creation\n             of a circular stapled anastomosis created within 10cm from the anal verge.\n\n          4. If female - not be of child bearing potential, or be using acceptable contraception\n             methods.\n\n          5. Subject participating in studies involving approved drug or device will be enrolled\n             only following a mutual consideration of the investigator together with the Sponsor.\n\n        Exclusion Criteria:\n\n          1. Subject has a history of hypersensitivity to porcine derived gelatin or collagen\n\n          2. Subject participating in any other study involving an investigational (unapproved)\n             drug or device.\n\n          3. Subject with a BMI higher than 40\n\n          4. Female Subject states that she is pregnant or breast feeding\n\n          5. Subject with ASA status higher than 3\n\n          6. Avastin use within 30 days prior to surgery\n\n          7. Subject who underwent a prior pelvic anastomosis\n\n          8. Subject is scheduled for another surgery during the follow up period of this study\n             (not including stoma closure)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02046278", 
            "org_study_id": "CLP-LS-0110"
        }, 
        "intervention": {
            "arm_group_label": "Device arm - Standard of Care + LifeSeal\u2122 Kit", 
            "intervention_name": "LifeSeal\u2122 Kit", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 17, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Kurt.Vanderspeeten@zol.be", 
                    "last_name": "Kurt Van Der Speeten, Prof", 
                    "phone": "+32-8-932-6524"
                }, 
                "facility": {
                    "address": {
                        "city": "Genk", 
                        "country": "Belgium"
                    }, 
                    "name": "Ziekenhuis Oost-Limburg"
                }, 
                "investigator": {
                    "last_name": "Kurt Van Der Speeten, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "saskia.degroote@uzgent.be", 
                    "last_name": "Saskia De Groote", 
                    "phone": "+32-9-332-4257"
                }, 
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium"
                    }, 
                    "name": "University Hospital"
                }, 
                "investigator": {
                    "last_name": "Yves VanNieuiwenhove@ugent.be, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "isabelle.terrasson@uzleuven.be", 
                    "last_name": "Isabelle Terrasson", 
                    "phone": "+32 16 340837"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium"
                    }, 
                    "name": "UZ Leuven"
                }, 
                "investigator": {
                    "last_name": "Andre' D'Hoore, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "anatw@tlvmc.gov.il", 
                    "last_name": "Anat Weizman"
                }, 
                "facility": {
                    "address": {
                        "city": "Tel Aviv", 
                        "country": "Israel"
                    }, 
                    "name": "Sourasky Medical Center"
                }, 
                "investigator": {
                    "last_name": "Hagit Tulchinsky, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ingrid.palmquist@med.lu.se", 
                    "last_name": "Ingrid Palmquist", 
                    "phone": "+46-40-333742"
                }, 
                "facility": {
                    "address": {
                        "city": "Malmo", 
                        "country": "Sweden"
                    }, 
                    "name": "Skane University Hospital"
                }, 
                "investigator": {
                    "last_name": "Ingvar Syk, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "madelene.ahlberg@karolinska.se", 
                    "last_name": "Madelene Ahlberg", 
                    "phone": "+46-8-51770378"
                }, 
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "Karolinska Institutet"
                }, 
                "investigator": {
                    "last_name": "Anna Martling, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "annika.liden@akademiska.se", 
                    "last_name": "Annika Lid\u00e9n", 
                    "phone": "+46 18 -611 92 26"
                }, 
                "facility": {
                    "address": {
                        "city": "Uppsala", 
                        "country": "Sweden", 
                        "zip": "SE-751 85"
                    }, 
                    "name": "Uppsala University Hospital"
                }, 
                "investigator": {
                    "last_name": "Joakim Folkesson, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Israel", 
                "Sweden"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "LifeSeal\u2122 Pilot Study in Subjects Undergoing Circular Stapled Anastomosis Created Within 10 cm of the Anal Verge", 
        "overall_contact": {
            "email": "Sachi@life-bond.com", 
            "last_name": "Sachi Norman, Dr.", 
            "phone": "+972-4-6373979"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Sweden: Medical Products Agency", 
                "Israel: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Assessment of the overall Subject safety by incidence of pre specified procedure related Adverse Events.", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 15 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02046278"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Performance Rate of anastomotic leak (both radiological and clinical leaks)", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 15 weeks post procedure or at stoma closure, whichever comes first"
        }, 
        "source": "LifeBond Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LifeBond Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}